Questions To Califf In Second Confirmation Hearing Similar To Predecessors
However, the few Senate questions about industry ties, tobacco and food issues may surprise some observers.
You may also be interested in...
Responding to Sen. Roger Marshall’s question on rulemaking to accelerate OTC switches by allowing NDA sponsors to use extra-label information to guide consumers through self-selection of a drug, Robert Califf said he’d support making progress on a proposal FDA began considering in 2012 in its NSURE initiative.
Robert Califf got 89 votes in the Senate last time – but that’s also the least a Democratic nominee has ever gotten.
The cardiologist seeking another term as FDA commissioner has been working in the pharma industry since leaving the post, but Senators have tended not to question nominee's work history extensively during previous confirmation hearings.